Our findings revealed a progressive decline in FFAR4 expression among non‐smokers, smokers, and COPD patients, concurrent with elevated levels of P53 and P21 (Figure 4A). This evidence concerns the gene FFAR4 and chronic obstructive pulmonary disease.